Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/2547| Title: | Guidelines for the use of epoetin: Have quality-of-life benefits been proven? | Authors: | Bottomley, A Thomas, R VAN STEEN, Kristel Flechtner, H de Graeff, A |
Issue Date: | 2003 | Publisher: | AMER SOC CLINICAL ONCOLOGY | Source: | JOURNAL OF CLINICAL ONCOLOGY, 21(11). p. 2223-2223 | Notes: | European Org Res Treatment Canc, Ctr Data, Brussels, Belgium. Limburgs Univ Ctr, Ctr Stat, Diepenbeek, Belgium. Univ Cologne, Klin Psychiat & Psychotherapiedes Kindes & Jugend, Cologne, Germany. Univ Utrecht, Med Ctr, Utrecht, Netherlands.Bottomley, A, European Org Res Treatment Canc, Ctr Data, Brussels, Belgium. | Document URI: | http://hdl.handle.net/1942/2547 | ISSN: | 0732-183X | e-ISSN: | 1527-7755 | ISI #: | 000183211400027 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2004 |
| Appears in Collections: | Research publications |
Show full item record
WEB OF SCIENCETM
Citations
4
checked on May 2, 2024
Page view(s)
66
checked on Jul 31, 2023
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.